Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice-Reference-Cited by-同舟云学术

Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice

Published:2014-04-01 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nomura Johji,Busso Nathalie,Ives Annette,Matsui Chieko,Tsujimoto Syunsuke,Shirakura Takashi,Tamura Mizuho,Kobayashi Tsunefumi,So Alexander,Yamanaka Yoshihiro

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep04554.pdf

Reference38 articles.

1. Yang, Z. & Ming, X. F. Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol 4, 149 (2013).

2. Lonn, M. E., Dennis, J. M. & Stocker, R. Actions of “antioxidants” in the protection against atherosclerosis. Free Radic Biol Med 53, 863–84 (2012).

3. Riccioni, G. & Sblendorio, V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol 9, 305–17 (2012).

4. Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat Immunol 12, 204–12 (2011).

5. Mudau, M., Genis, A., Lochner, A. & Strijdom, H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr 23, 222–31 (2012).

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of ROS and autophagy in the pathological process of atherosclerosis;Journal of Physiology and Biochemistry;2024-08-07

2. Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis;Kidney Medicine;2024-08

3. Significance and amplification methods of the purine salvage pathway in human brain cells;Journal of Biological Chemistry;2024-08

4. Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways;Immunopharmacology and Immunotoxicology;2024-07-03

5. Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis;Molecular Neurobiology;2024-03-18